Preferred Label : Regulatory Action;
NCIt related terms : Action;
NCIt definition : A regulatory measure taken against an entity, such as a company, or a product, such
as a drug.;
NCI Metathesaurus CUI : CL973413;
Origin ID : C162846;
UMLS CUI : C5202992;
Automatic exact mappings (from CISMeF team)
Semantic type(s)
concept_is_in_subset
https://www.academie-medecine.fr/linnovation-en-sante-une-action-volontariste-de-letat-face-a-la-complexite-de-son-organisation/
2024
France
technical report
face
Drinking Status
organization
health status
Regulatory Action
Study Site Accrual Status
Health Status
organizers, embryonic
Organization
Organization Name
Other Agency or Organization
organizations
---
https://www.anses.fr/fr/system/files/NUT2023VIG0188.pdf
2024
France
public health guidelines
Polypodium leucotomos Extract
Hallucinations, CTCAE
dietary supplements
Breast Cancer Anti-Estrogen Resistance Protein 1
True Case Status
eating
Case
Food Consumption
CTNND1 wt Allele
Coronavirus Anxiety Scale
hallucinations
Hallucination
Neither Agree or Disagree
Have Not Tried It
Case Dosing Unit
inlets
Packaging Case
Regulatory Action
triplets
snacks
bays
Relative Value
judgment
BCAR1 wt Allele
hallucination, nos
No Cases Transmission Pattern
Catenin Delta-1
---
https://dumas.ccsd.cnrs.fr/dumas-04554843
2024
France
dissertations, academic
Reviewing
Charge
episode of
review literature as topic
Prolonged Release Mechanism of Action
antipsychotic agents
patient care management
Episode
Antipsychotic Agent
Regulatory Action
Extraction
long
---
https://www.bag.admin.ch/bag/fr/home/das-bag/aktuell/news/news-26-06-2024-2.html
2024
France
scientific and technical information
drug resistance, microbial
news
Plan
communication
Shared
Regulatory Action
communism
---
https://publications.msss.gouv.qc.ca/msss/document-003734/
2024
Canada
technical report
aging
government programs
Aging
Regulatory Action
government
Plan
aging
---
https://www.who.int/fr/publications-detail/9789240090538
2024
Switzerland
public health guidelines
Strategy
Global Health
tooth, nos
Plan
oral health
Dental Dosage Form
Dental Route of Administration
Regulatory Action
---
http://beh.santepubliquefrance.fr/beh/2024/9/2024_9_0.html
2024
France
journal article
Attributable, Legible, Contemporaneous, Original, Accurate Plus
Alcohol
french
Prevention
Public Health
public health
Engaged
Attributable, Legible, Contemporaneous, Original, Accurate
Ethanol
alcohol, nos
CHFR Gene
Regulatory Action
ethyl alcohol
france
science
alcoholics
Prevention Study
Involvement
preventive medicine
alcoholism
Preventive Intervention
Ethanol Measurement
alcohols
Health Promotion Sciences
---
https://sesstim.univ-amu.fr/fr/video-box/seminaire-du-reseau-francophone-de-litteratie-en-sante-nicolas-giraudeau
2024
France
audiovisual aids
Adjuvant Post-operative Pharmaceutical Therapy Was Not Administered
Another Form of Birth Control was not Used
Medical Examination
BRAF Mutation Analysis Was Not Performed
Unemployed
No Response to Intervention for Kawasaki Disease
Preventive
Use of Smokeless Tobacco at Time of Diagnosis Negative
Family History of Stomach Cancer Absent
No Known History of Illicit Drug Use
No History of Other Muscular Dystrophy or Glycogen Storage Disorder
RET Rearrangement Analysis Was Not Performed
Negation
Adjuvant Post-operative Chemotherapy Was Not Administered
KRAS Mutation Analysis Was Not Performed
Chemical/Occupational Exposure Absent
IV Anesthesia was not Administered
health literacy
Caffeine Not Routinely Consumed
Literacy
Interferon Gamma Treatment was not Administered 90 Days Prior to Specimen Resection
IDH Family Wildtype
Additional Molecular Studies Were Not Performed
Minor Criteria for Rheumatic Heart Disease Not Present
Not Lost to Follow-Up
Documentation Absent
NRAS Mutation Analysis Was Not Performed
Scheduled
Immunotherapy Was Not Administered as an Additional Treatment for a New Tumor Event
Adjuvant Post-operative Radiation Therapy Was Not Administered
EGFR Mutation Analysis Was Not Performed
Peripheral Blood Immunophenotyping and Cytochemistry Were Not Performed
Regular Smokeless Tobacco Use for Six Weeks or More Negative
Any Metastatic Diagnosis Absent
No History of Neonatal Complication
PTEN Mutation Analysis Was Not Performed
NF1 Mutation Analysis Was Not Performed
Regional Anesthesia was not Administered
Paraneoplastic Syndrome is Not Present
No History of Myopathy
ATRX Mutation Analysis Was Not Performed
Other Preoperative IV Medications were not Administered
Fluorescence In Situ Hybridization Was Not Performed
SDH Complex Mutation Analysis Was Not Performed
Schedule
EGFR Gene Amplification Negative
ERBB2 Mutation Analysis Was Not Performed
No History of Congenital Heart Disease
Adjuvant I-131 Therapy Negative
Subsequent Known Primary Melanoma(s) Not Found During the Follow-Up
BRAF Rearrangement Analysis Was Not Performed
Tumor Progression Absent After Initial Treatment
TP53 Mutation Analysis Was Not Performed
Adjuvant Post-operative Immunological Therapy Was Not Administered
First Degree Family History Cancer Negative
No Known History of Alcohol Use
EGFR Amplification Analysis Was Not Performed
Additional Immunohistochemistry Was Not Performed
First Degree Family History of Primary Brain Tumor Negative
Radiation Therapy Not Received
Chemotherapy Was Not Administered as an Additional Treatment for a New Tumor Event
medical computer science
No History of Gestational Complication
digitalis, nos
New Tumor Event After Initial Treatment Absent
ATRX Gene Mutation Negative
Evidence of Disease Absent after Completion of Therapy
Adjuvant Post-operative Targeted Molecular Therapy Was Not Administered
Local Anesthesia Agents were not Administered
NON Mouse
Chemotherapy Not Received
PTEN Gene Mutation Negative
Radiation Was Not Administered as an Additional Treatment for a New Tumor Event
digitalis
Nitric Oxide
Medication Not Taken
Hypertension Absent
Lymph Node Dissection Was Not Performed
No History of Non-Cardiac Surgery
History of Medical Treatment Absent
Patient was Not Previously Evaluated for Current Chief Complaint
IDH Family Mutation Analysis Was Not Performed
ROS1 Rearrangement Analysis Was Not Performed
program evaluation
KIT Mutation Analysis Was Not Performed
Hormone Therapy Was Not Administered as an Additional Treatment for a New Tumor Event
Radiation History Negative
Preoperative IV Antacids were not Administered
Additional Surgery for New Metastatic Tumor Event Was Not Performed
Additional Surgery for New Tumor Event Absent
Preoperative IV Antiemetics were not Administered
Physician Diagnosed Diabetes Absent
Has No Sibling
Digitalis
Routine Cytogenetics Were not Completed
Neither
Nitric Oxide Measurement
Regulatory Action
Bone Marrow Aspirate Immunophenotyping and Cytochemistry Were Not Performed
Interferon Gamma Treatment was not Administered Prior to Specimen Resection
No History of Rheumatic Fever
Preoperative IV Sedation was Not Administered
Therapeutic Ionizing Radiation to Head History Absent
MET Mutation Analysis Was Not Performed
Additional Surgery for New Loco-Regional Tumor Event Was Not Performed
Neither Case or Control Status
Targeted Molecular Therapy Was Not Administered as an Additional Treatment for a New
Tumor Event
Preoperative IV Opiates were not Administered
Norway
Intercurrent Illness is Absent at Onset of Chief Complaint
History of Colorectal Cancer Negative
Chief Complaint Not Caused by Trauma
Multiple Known Primary Tumors Absent at Initial Melanoma Diagnosis
Chief Complaint was Not Witnessed
10q23/PTEN Locus Deletion Analysis Was Not Performed
No History of Kawasaki Disease
New Disease is not Multifocal
PDGFRA Mutation Analysis Was Not Performed
non-communicating
MGMT Promoter Methylation Testing Was Not Performed
Intervention Not Given for Kawasaki Disease
Tumor Reoccurrence Absent After Initial Treatment
ALK Rearrangement Analysis Was Not Performed
First Degree Family History Thyroid Cancer Negative
Cancer History Absent
Patient was not Postmenopausal with no Prior Oophorectomy
1p/19q Deletion Analysis Was Not Performed
---
https://publications.msss.gouv.qc.ca/msss/document-003708/
2024
Canada
technical report
Early Childhood
childhood
Regulatory Action
perinatology
Plan
---
https://www.anses.fr/fr/content/glyphosate-le-point-sur-les-actions-de-lanses
2024
France
popular works
Glyphosate
Regulatory Action
glyphosate
Point
Point Name
inlets
Glyphosate
bays
---
https://www.inrs.fr/media.html?refINRS=ED%206530
2024
France
popular works
Occupational Health
oral health
occupational health
occupation, nos
tooth, nos
dental offices
Regulatory Action
Dental Dosage Form
Dental Route of Administration
---
https://publications.msss.gouv.qc.ca/msss/document-003695/
2024
Canada
technical report
Regulatory Action
Clinical Trial Development Plan
Sustainable Development
social change
---
https://publications.msss.gouv.qc.ca/msss/document-003694/
2024
Canada
technical report
disaster planning
Drug Delivery System
Emergency
Plan
Urgency
emergencies
Emergency Room
government
Regulatory Action
government programs
Device System
Drug Delivery System Category
---
https://publications.msss.gouv.qc.ca/msss/document-003684/
2024
Canada
technical report
Regulatory Action
Balance Sheet
People
Stooping
elder abuse
government
persons
Checkup
government programs
Plan
---
https://www.canal-u.tv/chaines/progedo/des-donnees-sur-le-vieillissement-besoins-et-contraintes-des-differents-champs-d
2024
France
audiovisual aids
health services needs and demand
Need
aging
action research
needs
Constrain
Restriction
Quantitative Constraint
Password Aging
Aging
Data Field
Regulatory Action
Research
stress, physiological
dataset
Search
aging
---
https://publications.msss.gouv.qc.ca/msss/document-003675/
2024
Canada
technical report
Balance Sheet
Regulatory Action
Checkup
limited function/disability nos
Disabled Population
handicap
Persons with Disabilities
Plan
---
https://iris.who.int/handle/10665/376108
2023
Switzerland
public health guidelines
Lupus Anticoagulant Antibody
Handbook
epidemics
Louisiana
Driving
Guide Device
leadership
Enhance
Epidemic Disorder
Improved
Lanthanum
Left Arm
Recursive Partitioning Assessment
Regulatory Action
Lao People's Democratic Republic
SSB wt Allele
RPA1 wt Allele
---
https://dumas.ccsd.cnrs.fr/dumas-04132931
2023
France
dissertations, academic
education
Education
Family Practice
Male Breast
COVID-19 Infection
Female Breast
achievement
COVID-19
During or After
gestures
Regulatory Action
general practice
Murine Breast
Biomedicine
acquaintance
Evolution
Status Post
insight, nos
breast
Education Level
knowledge
---
https://dumas.ccsd.cnrs.fr/dumas-04361127
2023
France
dissertations, academic
Medical Examination
association
What Month is it
Feasibility
nurse administrators
Regulatory Action
CDISC SDTM Environmental Setting Terminology
health promotion
evaluation studies as topic
Health Promotion
---
https://www.has-sante.fr/jcms/p_3482927/fr/avantgarde-chrono-carbostent
2023
France
health technology assessment
pharmacologist
Carbon
carbon, nos
Stent
pharmacologic actions
Pharmacology
Endoprosthesis
Cover
Regulatory Action
stents
Coronary Artery Stent
Product Part
Stenting
Pharmacologic Substance
Joy
carbon
Coat
---
https://www.who.int/fr/news-room/fact-sheets/detail/mental-health-strengthening-our-response
2023
Switzerland
popular works
scientific and technical information
Reinforcement, Psychology
reinforcement, nos
Mental Health
Regulatory Action
mental health
---
https://cps.ca/fr/documents/position/les-medias-sociaux-et-les-jeunes-un-appel-a-laction
2023
France
scientific and technical information
social media
Regulatory Action
Decision
Call
Internet Social Media
naming, nos
---
https://www.inspq.qc.ca/publications/3429
2023
Canada
technical report
Portrait
organization and administration
quebec
zoonosis, nos
zoonoses
Attention Concentration
Regulatory Action
Management
Zoonotic Infection
portraits as topic
---
https://iris.who.int/handle/10665/374736
2023
Switzerland
journal article
social conformity
Systemic Immunotherapy
Conformance
Patient Compliance
government programs
Device System
Local-Regional
systemic administration
Conformation
Drug Delivery System Category
Spouse
Ability
Drug Delivery System
Regional Disease
One Health
Capacity
Regulatory Action
Initiation
spouses
Approach
Capacitor Device
health systems plans
capacity building
Local
Route of Administration
world health organization
reinforcement, nos
Sontuzumab
Transcription Initiation
CDISC SDTM Route of Administration Terminology
Version
Plan
---
https://iris.who.int/handle/10665/374732
2023
Switzerland
journal article
Implementation
fertilization
One Health
conception
NCI Thesaurus Concept
Handbook
Spouse
Metathesaurus Concept
Guide Device
insurance pools
spouses
Plan
conception
Regulatory Action
---
https://www.has-sante.fr/jcms/p_3474526/fr/pro-kinetic-energy
2023
France
health technology assessment
pharmacologist
stents
Silicon
silicon carbide
Product Part
silicon carbide
silicon carbide
Stenting
Endoprosthesis
Stent
Proline Measurement
Pharmacology
Cover
Patient Reported Outcome
Proline
Coat
Pharmacologic Substance
Coronary Artery Stent
silicon
pharmacologic actions
Joy
Regulatory Action
proline
PRO Mouse
---
https://dumas.ccsd.cnrs.fr/dumas-04248048v1
2023
France
dissertations, academic
Regulatory Action
First Degree Family History Cancer Negative
Hormone Therapy Was Not Administered as an Additional Treatment for a New Tumor Event
Has No Sibling
10q23/PTEN Locus Deletion Analysis Was Not Performed
Therapeutic Ionizing Radiation to Head History Absent
Use of Smokeless Tobacco at Time of Diagnosis Negative
Bone Marrow Aspirate Immunophenotyping and Cytochemistry Were Not Performed
Regional Anesthesia was not Administered
Other Preoperative IV Medications were not Administered
PTEN Mutation Analysis Was Not Performed
Norway
Minor Criteria for Rheumatic Heart Disease Not Present
Interferon Gamma Treatment was not Administered 90 Days Prior to Specimen Resection
No History of Rheumatic Fever
Negation
Adjuvant Post-operative Pharmaceutical Therapy Was Not Administered
Radiation Therapy Not Received
Chief Complaint Not Caused by Trauma
Targeted Molecular Therapy Was Not Administered as an Additional Treatment for a New
Tumor Event
TP53 Mutation Analysis Was Not Performed
No Known History of Alcohol Use
1p/19q Deletion Analysis Was Not Performed
Additional Molecular Studies Were Not Performed
RET Rearrangement Analysis Was Not Performed
SDH Complex Mutation Analysis Was Not Performed
Research
Failure
Any Metastatic Diagnosis Absent
Additional Immunohistochemistry Was Not Performed
Intervention Not Given for Kawasaki Disease
Patient was not Postmenopausal with no Prior Oophorectomy
ATRX Gene Mutation Negative
Preoperative IV Opiates were not Administered
Hypertension Absent
ERBB2 Mutation Analysis Was Not Performed
Medication Not Taken
History of Colorectal Cancer Negative
Adjuvant Post-operative Radiation Therapy Was Not Administered
Adjuvant I-131 Therapy Negative
Adjuvant Post-operative Immunological Therapy Was Not Administered
Neither
Evidence of Disease Absent after Completion of Therapy
Nitric Oxide Measurement
Tumor Progression Absent After Initial Treatment
No History of Neonatal Complication
Additional Surgery for New Tumor Event Absent
Adjuvant Post-operative Targeted Molecular Therapy Was Not Administered
NF1 Mutation Analysis Was Not Performed
Neither Case or Control Status
Physician Diagnosed Diabetes Absent
Subsequent Known Primary Melanoma(s) Not Found During the Follow-Up
Additional Surgery for New Metastatic Tumor Event Was Not Performed
IV Anesthesia was not Administered
Chemical/Occupational Exposure Absent
Preoperative IV Antiemetics were not Administered
Participation
No History of Other Muscular Dystrophy or Glycogen Storage Disorder
IDH Family Wildtype
BRAF Mutation Analysis Was Not Performed
Chemotherapy Was Not Administered as an Additional Treatment for a New Tumor Event
Preoperative IV Antacids were not Administered
Caffeine Not Routinely Consumed
ATRX Mutation Analysis Was Not Performed
Peripheral Blood Immunophenotyping and Cytochemistry Were Not Performed
First Degree Family History Thyroid Cancer Negative
Regular Smokeless Tobacco Use for Six Weeks or More Negative
PDGFRA Mutation Analysis Was Not Performed
Not Lost to Follow-Up
Search
Tumor Reoccurrence Absent After Initial Treatment
No Known History of Illicit Drug Use
Nitric Oxide
Interferon Gamma Treatment was not Administered Prior to Specimen Resection
NON Mouse
Preoperative IV Sedation was Not Administered
Radiation History Negative
No History of Non-Cardiac Surgery
NRAS Mutation Analysis Was Not Performed
Fluorescence In Situ Hybridization Was Not Performed
No History of Congenital Heart Disease
IDH Family Mutation Analysis Was Not Performed
ROS1 Rearrangement Analysis Was Not Performed
Chemotherapy Not Received
History of Medical Treatment Absent
Patient was Not Previously Evaluated for Current Chief Complaint
Unemployed
play and playthings
MGMT Promoter Methylation Testing Was Not Performed
Documentation Absent
Lymph Node Dissection Was Not Performed
No History of Gestational Complication
No History of Myopathy
health services research
Immunotherapy Was Not Administered as an Additional Treatment for a New Tumor Event
PTEN Gene Mutation Negative
Cancer History Absent
Paraneoplastic Syndrome is Not Present
EGFR Mutation Analysis Was Not Performed
action research
No Response to Intervention for Kawasaki Disease
Radiation Was Not Administered as an Additional Treatment for a New Tumor Event
Family History of Stomach Cancer Absent
New Tumor Event After Initial Treatment Absent
No History of Kawasaki Disease
Chief Complaint was Not Witnessed
Another Form of Birth Control was not Used
EGFR Amplification Analysis Was Not Performed
Local Anesthesia Agents were not Administered
Intercurrent Illness is Absent at Onset of Chief Complaint
New Disease is not Multifocal
Adjuvant Post-operative Chemotherapy Was Not Administered
MET Mutation Analysis Was Not Performed
Routine Cytogenetics Were not Completed
Additional Surgery for New Loco-Regional Tumor Event Was Not Performed
ALK Rearrangement Analysis Was Not Performed
KIT Mutation Analysis Was Not Performed
play
First Degree Family History of Primary Brain Tumor Negative
EGFR Gene Amplification Negative
Multiple Known Primary Tumors Absent at Initial Melanoma Diagnosis
BRAF Rearrangement Analysis Was Not Performed
KRAS Mutation Analysis Was Not Performed
---
https://theses.fr/2023UNIP7053
2023
France
dissertations, academic
Public
french
CHFR Gene
prescription, nos
publications
general practitioners
france
Regulatory Action
---
https://www.health.belgium.be/fr/avis-9792-nehap3
2023
Belgium
technical report
environmental health
Regulatory Action
Environmental
Approximate
Plan
Surrounding
third
government programs
---
https://www.creaibfc.org/wp-content/uploads/guide_fin_de_vie.pdf
2023
France
handbooks
Near
dental articulators
End
joints
Ankle Joint
Endoglin
personal autonomy
ENG wt Allele
Disabled Population
Joint Device
Bowl Dosing Unit
Streaking Artifact
Guide Device
handicap
VIE Regimen
Jogging
life
caregivers
limited function/disability nos
terminally ill
Vietnamese Language
Banding Artifact
self determination
Jaw Joint
Joy
Handbook
Prepared Material
Joint Stock Company
Life
Methaqualone
Persons with Disabilities
Stifle Joint
Shading Artifact
Articulation
Go Jogging or Running
Rat Joint
Regulatory Action
Finnish Language
Finland
Nearest
End Time
Laser-Induced Fluorescence Endoscopy
Murine Joints
articulators
Preparation
---
https://www.inspq.qc.ca/publications/3391
2023
Canada
review of literature
Application Context
Restriction
Health Equity
Regulatory Action
Fair
---
https://dumas.ccsd.cnrs.fr/dumas-04157769
2023
France
dissertations, academic
has patient
Education Level
patient education as topic
neurodegenerative diseases
therapeutics
Youth
critical pathways
pharmacist
education
Questionnaire Not Completed Due to Patient Illness
Regulatory Action
Intervention
Education
disease, nos
Protocol Treatment Arm Molecular Target
pharmacists
Intervention for Congenital Heart Disease
adolescent
---
https://www.who.int/fr/publications-detail/9789290234449
2020
Switzerland
handbooks
Increment
wrestling
Regulatory Action
Treatment Step
Handbook
CDISC SEND Country Terminology
cancrum oris
government programs
Noma
Country Code
noma
Netherlands
Step
Stair
Guide Device
Step Unit of Distance
---